Role of budesonide as maintenance therapy for children with asthma.
Asthma is a chronic inflammatory disease of the airways. Inhaled corticosteroids are recognized as the preferred long-term control medication for persistent asthma based on their anti-inflammatory properties and significant evidence of efficacy. Inhaled budesonide is the most carefully characterized inhaled corticosteroid for childhood asthma. It is available for administration in children down to six months of age and to date has an excellent safety profile.
Szefler
Stanley
S
Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado, USA. szeflers@njc.org
Pedersen
Søren
S
D000280:Administration, Inhalation; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001249:Asthma / Q000175:diagnosis* / Q000188:drug therapy*; D015519:Bone Density / Q000187:drug effects; D019819:Budesonide / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002657:Child Development / Q000187:drug effects; D002675:Child, Preschool; D018849:Controlled Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006130:Growth Disorders / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008297:Male; D009330:Nebulizers and Vaporizers; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D019819:Budesonide